fosinopril has been researched along with Ventricular Dysfunction, Left in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ivkin, D; Karpov, A; Kaschina, E; Krasnova, M; Kulikov, A; Okovityi, S; Smirnov, A | 1 |
| Szucs, TD | 1 |
| Frank, H; Globits, S; Hoffmann, U; Kostner, K; Loewe, C; Stefenelli, T | 1 |
1 review(s) available for fosinopril and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Pharmacoeconomics of angiotensin converting enzyme inhibitors in heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Cost-Benefit Analysis; Costs and Cost Analysis; Delivery of Health Care; Economics, Pharmaceutical; Fosinopril; Heart Failure; Hospital Charges; Humans; Ventricular Dysfunction, Left | 1997 |
1 trial(s) available for fosinopril and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
The effects of ACE inhibitor therapy on left ventricular myocardial mass and diastolic filling in previously untreated hypertensive patients: a cine MRI study.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Cardiac Volume; Diastole; Female; Follow-Up Studies; Fosinopril; Heart Ventricles; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardium; Prospective Studies; Ventricular Dysfunction, Left | 2001 |
1 other study(ies) available for fosinopril and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Comparative efficacy of empagliflozin and drugs of baseline therapy in post-infarct heart failure in normoglycemic rats.
Topics: Animals; Benzhydryl Compounds; Bisoprolol; Cardiovascular Agents; Chronic Disease; Disease Models, Animal; Exercise Tolerance; Fosinopril; Glucosides; Heart Failure; Male; Myocardial Infarction; Rats, Wistar; Sodium-Glucose Transporter 2 Inhibitors; Spironolactone; Ventricular Dysfunction, Left; Ventricular Function, Left | 2020 |